Tekla Capital Management as of Dec. 31, 2014
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 92 positions in its portfolio as reported in the December 2014 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 10.4 | $223M | 2.0M | 111.86 | |
| Gilead Sciences (GILD) | 9.2 | $196M | 2.1M | 94.26 | |
| Biogen Idec (BIIB) | 5.2 | $111M | 327k | 339.45 | |
| Alexion Pharmaceuticals | 4.1 | $88M | 477k | 185.03 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.9 | $83M | 702k | 118.80 | |
| Regeneron Pharmaceuticals (REGN) | 3.8 | $81M | 199k | 410.25 | |
| Actavis | 3.4 | $72M | 278k | 257.41 | |
| Incyte Corporation (INCY) | 3.2 | $69M | 937k | 73.11 | |
| Amgen (AMGN) | 2.8 | $61M | 381k | 159.29 | |
| Shire | 2.8 | $60M | 282k | 212.54 | |
| Mylan | 2.7 | $57M | 1.0M | 56.37 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $52M | 570k | 90.40 | |
| Pfizer (PFE) | 2.4 | $51M | 1.6M | 31.15 | |
| Allergan | 2.3 | $49M | 228k | 212.59 | |
| Abbvie (ABBV) | 1.8 | $39M | 594k | 65.44 | |
| Johnson & Johnson (JNJ) | 1.6 | $34M | 327k | 104.57 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $33M | 202k | 163.73 | |
| Bristol Myers Squibb (BMY) | 1.5 | $32M | 535k | 59.03 | |
| Akorn | 1.4 | $31M | 850k | 36.20 | |
| Aetna | 1.4 | $30M | 332k | 88.83 | |
| Alkermes (ALKS) | 1.2 | $26M | 437k | 58.56 | |
| Teva Pharmaceutical Industries (TEVA) | 1.1 | $24M | 424k | 57.51 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $22M | 1.0M | 22.34 | |
| NPS Pharmaceuticals | 1.1 | $22M | 626k | 35.77 | |
| Catamaran | 1.1 | $22M | 434k | 51.75 | |
| Ventas (VTR) | 1.0 | $21M | 293k | 71.70 | |
| Synageva Biopharma | 1.0 | $21M | 223k | 92.79 | |
| Allscripts Healthcare Solutions (MDRX) | 1.0 | $21M | 1.6M | 12.77 | |
| Illumina (ILMN) | 0.9 | $19M | 104k | 184.58 | |
| Molina Healthcare (MOH) | 0.9 | $19M | 348k | 53.53 | |
| Endo International | 0.8 | $18M | 252k | 72.12 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.8 | $18M | 58k | 303.35 | |
| Physicians Realty Trust | 0.7 | $16M | 958k | 16.60 | |
| Thermo Fisher Scientific (TMO) | 0.7 | $15M | 121k | 125.29 | |
| Omega Healthcare Investors (OHI) | 0.7 | $15M | 376k | 39.07 | |
| McKesson Corporation (MCK) | 0.7 | $14M | 68k | 207.58 | |
| Medical Properties Trust (MPW) | 0.6 | $14M | 979k | 13.78 | |
| Health Care Reit Pfd I 6.5% | 0.6 | $13M | 200k | 65.85 | |
| Eli Lilly & Co. (LLY) | 0.6 | $13M | 187k | 68.99 | |
| Momenta Pharmaceuticals | 0.6 | $13M | 1.1M | 12.04 | |
| Sabra Health Care REIT (SBRA) | 0.6 | $12M | 408k | 30.37 | |
| Ironwood Pharmaceuticals (IRWD) | 0.6 | $12M | 768k | 15.32 | |
| Celladon | 0.6 | $12M | 607k | 19.53 | |
| Alere | 0.5 | $11M | 298k | 38.00 | |
| Acorda Therapeutics | 0.5 | $11M | 273k | 40.87 | |
| Impax Laboratories | 0.5 | $11M | 345k | 31.68 | |
| Hca Holdings (HCA) | 0.5 | $11M | 148k | 73.39 | |
| Verastem | 0.5 | $11M | 1.1M | 9.14 | |
| Perrigo Company (PRGO) | 0.5 | $11M | 63k | 167.16 | |
| Sangamo Biosciences (SGMO) | 0.5 | $10M | 679k | 15.21 | |
| LTC Properties (LTC) | 0.5 | $10M | 237k | 43.17 | |
| Corsicanto Ltd conv bnd | 0.4 | $9.1M | 15M | 0.62 | |
| Stryker Corporation (SYK) | 0.4 | $9.0M | 96k | 94.33 | |
| Zimmer Holdings (ZBH) | 0.4 | $9.1M | 80k | 113.42 | |
| Senior Housing Properties Trust | 0.4 | $9.1M | 410k | 22.11 | |
| Heron Therapeutics (HRTX) | 0.4 | $8.8M | 874k | 10.06 | |
| IDEXX Laboratories (IDXX) | 0.4 | $8.3M | 56k | 148.26 | |
| Community Health Systems (CYH) | 0.4 | $8.3M | 155k | 53.92 | |
| Endologix | 0.4 | $8.4M | 551k | 15.29 | |
| St. Jude Medical | 0.4 | $8.0M | 123k | 65.03 | |
| CIGNA Corporation | 0.4 | $7.6M | 74k | 102.91 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $7.4M | 439k | 16.89 | |
| WellCare Health Plans | 0.3 | $7.3M | 89k | 82.06 | |
| Eleven Biotherapeutics | 0.3 | $6.5M | 610k | 10.69 | |
| Merrimack Pharmaceuticals In | 0.3 | $6.4M | 568k | 11.30 | |
| Centene Corporation (CNC) | 0.3 | $6.2M | 60k | 103.85 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $6.2M | 119k | 51.77 | |
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $6.0M | 62k | 97.00 | |
| Accuray Incorporated (ARAY) | 0.3 | $5.5M | 732k | 7.55 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $5.2M | 46k | 112.03 | |
| Karyopharm Therapeutics (KPTI) | 0.2 | $5.2M | 138k | 37.43 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $5.0M | 345k | 14.47 | |
| Bluebird Bio (BLUE) | 0.2 | $5.0M | 55k | 91.72 | |
| Wright Medical | 0.2 | $4.2M | 156k | 26.87 | |
| Myriad Genetics (MYGN) | 0.2 | $3.8M | 112k | 34.06 | |
| Kythera Biopharmaceuticals I | 0.2 | $3.9M | 111k | 34.68 | |
| Ligand Pharmaceuticals In (LGND) | 0.2 | $3.7M | 69k | 53.21 | |
| BioDelivery Sciences International | 0.2 | $3.4M | 283k | 12.02 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.2 | $3.5M | 2.0M | 1.74 | |
| Intellipharmaceuticsintl Inc C | 0.1 | $3.2M | 1.4M | 2.26 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $2.8M | 1.5M | 1.91 | |
| Receptos | 0.1 | $2.5M | 20k | 122.50 | |
| Dicerna Pharmaceuticals | 0.1 | $2.6M | 156k | 16.47 | |
| Sagent Pharmaceuticals | 0.1 | $2.1M | 86k | 25.11 | |
| Sorrento Therapeutics (SRNE) | 0.1 | $2.2M | 214k | 10.07 | |
| Bellicum Pharma | 0.1 | $1.4M | 60k | 23.03 | |
| Mei Pharma | 0.1 | $1.0M | 244k | 4.27 | |
| Zafgen | 0.0 | $821k | 27k | 30.85 | |
| Macrogenics (MGNX) | 0.0 | $447k | 13k | 35.08 | |
| OncoGenex Pharmaceuticals | 0.0 | $259k | 113k | 2.29 | |
| Sage Therapeutics (SAGE) | 0.0 | $183k | 5.0k | 36.60 | |
| Clovis Oncology | 0.0 | $3.0k | 51.00 | 58.82 |
